Gastrointestinal Therapeutics Market Insights and Growth by 2031
Gastrointestinal diseases refer to the medical conditions which are related to the digestive tract and the other organs associated during the process of digestion. The gastrointestinal tract consists of organs such as the esophagus, stomach, small & large intestine, and rectum. The accessory organs used while the process of digestion includes liver, gallbladder, and pancreas. Gastrointestinal therapeutics is a branch of medicine that provides treatment for gastrointestinal disease and decides the action of remedial agents.
MARKET DYNAMICS
The gastrointestinal therapeutics market is anticipated to grow in the forecast, owing to the growing cases of gastrointestinal infections along with the increasing aging population. In addition, the rising adoption of unhealthy food eating habits is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Gastrointestinal Therapeutics Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of gastrointestinal therapeutics market with detailed market segmentation by type, route of administration, application, distribution channel, and geography. The global gastrointestinal therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gastrointestinal therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global gastrointestinal therapeutics market is segmented on the basis of type, route of administration, application, and distribution channel. Based on type, the market is segmented as, branded and generics. The gastrointestinal therapeutics market is categorized based on route of administration such as, oral, intravenous, and others. On the basis of application, the market is segmented as, ulcerative colitis, crohn's disease, gastroesophageal reflux disease (GERD), and other applications. Similarly, based on distribution channel, the gastrointestinal therapeutics market is classified as, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gastrointestinal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gastrointestinal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gastrointestinal therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gastrointestinal therapeutics market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gastrointestinal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gastrointestinal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gastrointestinal therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gastrointestinal therapeutics market in these regions.
MARKET PLAYERS
The report covers key developments in the gastrointestinal therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gastrointestinal therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for gastrointestinal therapeutics market in the global market. Below mentioned is the list of few companies engaged in the gastrointestinal therapeutics market.
The report also includes the profiles of key gastrointestinal therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott
- AbbVie Inc.
- ALLERGAN
- AstraZeneca
- Bayer AG
- GlaxoSmithKline plc.
- Janssen Global Services, LLC
- Pfizer Inc.
- Salix Pharmaceuticals
- Takeda Pharmaceutical Company Limited
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastrointestinal Therapeutics Market - By Type
1.3.2 Gastrointestinal Therapeutics Market - By Route of Administration
1.3.3 Gastrointestinal Therapeutics Market - By Application
1.3.4 Gastrointestinal Therapeutics Market - By Distribution Channel
1.3.5 Gastrointestinal Therapeutics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTROINTESTINAL THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTROINTESTINAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GASTROINTESTINAL THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANDED
7.3.1. Overview
7.3.2. Branded Market Forecast and Analysis
7.3.3. Aminosalicylates Market
7.3.3.1. Overview
7.3.3.2. Aminosalicylates Market Forecast and Analysis
7.3.4. Antacids Market
7.3.4.1. Overview
7.3.4.2. Antacids Market Forecast and Analysis
7.3.5. Enzyme Replacement Therapies Market
7.3.5.1. Overview
7.3.5.2. Enzyme Replacement Therapies Market Forecast and Analysis
7.3.6. Proton Pump Inhibitors Market
7.3.6.1. Overview
7.3.6.2. Proton Pump Inhibitors Market Forecast and Analysis
7.3.7. Laxatives Market
7.3.7.1. Overview
7.3.7.2. Laxatives Market Forecast and Analysis
7.3.8. Antiemetics Market
7.3.8.1. Overview
7.3.8.2. Antiemetics Market Forecast and Analysis
7.3.9. H2 Antagonists Market
7.3.9.1. Overview
7.3.9.2. H2 Antagonists Market Forecast and Analysis
7.3.10. Antidiarrheals Market
7.3.10.1. Overview
7.3.10.2. Antidiarrheals Market Forecast and Analysis
7.3.11. Biologics Market
7.3.11.1. Overview
7.3.11.2. Biologics Market Forecast and Analysis
7.3.12. Others Market
7.3.12.1. Overview
7.3.12.2. Others Market Forecast and Analysis
7.4. GENERICS
7.4.1. Overview
7.4.2. Generics Market Forecast and Analysis
8. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ULCERATIVE COLITIS
9.3.1. Overview
9.3.2. Ulcerative Colitis Market Forecast and Analysis
9.4. CROHN'S DISEASE
9.4.1. Overview
9.4.2. Crohn's Disease Market Forecast and Analysis
9.5. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
9.5.1. Overview
9.5.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9.6. OTHER APPLICATIONS
9.6.1. Overview
9.6.2. Other Applications Market Forecast and Analysis
10. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. GASTROINTESTINAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Gastrointestinal Therapeutics Market Overview
11.1.2 North America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.1.3 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.1.4 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.1.6 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Gastrointestinal Therapeutics Market
11.1.7.1.1 United States Gastrointestinal Therapeutics Market by Type
11.1.7.1.2 United States Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.1.3 United States Gastrointestinal Therapeutics Market by Application
11.1.7.1.4 United States Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.2 Canada Gastrointestinal Therapeutics Market
11.1.7.2.1 Canada Gastrointestinal Therapeutics Market by Type
11.1.7.2.2 Canada Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.2.3 Canada Gastrointestinal Therapeutics Market by Application
11.1.7.2.4 Canada Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.3 Mexico Gastrointestinal Therapeutics Market
11.1.7.3.1 Mexico Gastrointestinal Therapeutics Market by Type
11.1.7.3.2 Mexico Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.3.3 Mexico Gastrointestinal Therapeutics Market by Application
11.1.7.3.4 Mexico Gastrointestinal Therapeutics Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Gastrointestinal Therapeutics Market Overview
11.2.2 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis
11.2.3 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.2.4 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.2.6 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Gastrointestinal Therapeutics Market
11.2.7.1.1 Germany Gastrointestinal Therapeutics Market by Type
11.2.7.1.2 Germany Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.1.3 Germany Gastrointestinal Therapeutics Market by Application
11.2.7.1.4 Germany Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.2 France Gastrointestinal Therapeutics Market
11.2.7.2.1 France Gastrointestinal Therapeutics Market by Type
11.2.7.2.2 France Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.2.3 France Gastrointestinal Therapeutics Market by Application
11.2.7.2.4 France Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.3 Italy Gastrointestinal Therapeutics Market
11.2.7.3.1 Italy Gastrointestinal Therapeutics Market by Type
11.2.7.3.2 Italy Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.3.3 Italy Gastrointestinal Therapeutics Market by Application
11.2.7.3.4 Italy Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.4 Spain Gastrointestinal Therapeutics Market
11.2.7.4.1 Spain Gastrointestinal Therapeutics Market by Type
11.2.7.4.2 Spain Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.4.3 Spain Gastrointestinal Therapeutics Market by Application
11.2.7.4.4 Spain Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.5 United Kingdom Gastrointestinal Therapeutics Market
11.2.7.5.1 United Kingdom Gastrointestinal Therapeutics Market by Type
11.2.7.5.2 United Kingdom Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.5.3 United Kingdom Gastrointestinal Therapeutics Market by Application
11.2.7.5.4 United Kingdom Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.6 Rest of Europe Gastrointestinal Therapeutics Market
11.2.7.6.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
11.2.7.6.2 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.6.3 Rest of Europe Gastrointestinal Therapeutics Market by Application
11.2.7.6.4 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Overview
11.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Gastrointestinal Therapeutics Market
11.3.7.1.1 Australia Gastrointestinal Therapeutics Market by Type
11.3.7.1.2 Australia Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.1.3 Australia Gastrointestinal Therapeutics Market by Application
11.3.7.1.4 Australia Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.2 China Gastrointestinal Therapeutics Market
11.3.7.2.1 China Gastrointestinal Therapeutics Market by Type
11.3.7.2.2 China Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.2.3 China Gastrointestinal Therapeutics Market by Application
11.3.7.2.4 China Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.3 India Gastrointestinal Therapeutics Market
11.3.7.3.1 India Gastrointestinal Therapeutics Market by Type
11.3.7.3.2 India Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.3.3 India Gastrointestinal Therapeutics Market by Application
11.3.7.3.4 India Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.4 Japan Gastrointestinal Therapeutics Market
11.3.7.4.1 Japan Gastrointestinal Therapeutics Market by Type
11.3.7.4.2 Japan Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.4.3 Japan Gastrointestinal Therapeutics Market by Application
11.3.7.4.4 Japan Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.5 South Korea Gastrointestinal Therapeutics Market
11.3.7.5.1 South Korea Gastrointestinal Therapeutics Market by Type
11.3.7.5.2 South Korea Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.5.3 South Korea Gastrointestinal Therapeutics Market by Application
11.3.7.5.4 South Korea Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Gastrointestinal Therapeutics Market
11.3.7.6.1 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Type
11.3.7.6.2 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Application
11.3.7.6.4 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Gastrointestinal Therapeutics Market Overview
11.4.2 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Gastrointestinal Therapeutics Market
11.4.7.1.1 South Africa Gastrointestinal Therapeutics Market by Type
11.4.7.1.2 South Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.1.3 South Africa Gastrointestinal Therapeutics Market by Application
11.4.7.1.4 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.2 Saudi Arabia Gastrointestinal Therapeutics Market
11.4.7.2.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
11.4.7.2.2 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.2.3 Saudi Arabia Gastrointestinal Therapeutics Market by Application
11.4.7.2.4 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.3 U.A.E Gastrointestinal Therapeutics Market
11.4.7.3.1 U.A.E Gastrointestinal Therapeutics Market by Type
11.4.7.3.2 U.A.E Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.3.3 U.A.E Gastrointestinal Therapeutics Market by Application
11.4.7.3.4 U.A.E Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market
11.4.7.4.1 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Type
11.4.7.4.2 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Application
11.4.7.4.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Gastrointestinal Therapeutics Market Overview
11.5.2 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.5.4 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.5.6 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Gastrointestinal Therapeutics Market
11.5.7.1.1 Brazil Gastrointestinal Therapeutics Market by Type
11.5.7.1.2 Brazil Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.1.3 Brazil Gastrointestinal Therapeutics Market by Application
11.5.7.1.4 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.2 Argentina Gastrointestinal Therapeutics Market
11.5.7.2.1 Argentina Gastrointestinal Therapeutics Market by Type
11.5.7.2.2 Argentina Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.2.3 Argentina Gastrointestinal Therapeutics Market by Application
11.5.7.2.4 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.3 Rest of South and Central America Gastrointestinal Therapeutics Market
11.5.7.3.1 Rest of South and Central America Gastrointestinal Therapeutics Market by Type
11.5.7.3.2 Rest of South and Central America Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Gastrointestinal Therapeutics Market by Application
11.5.7.3.4 Rest of South and Central America Gastrointestinal Therapeutics Market by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GASTROINTESTINAL THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALLERGAN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BAYER AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JANSSEN GLOBAL SERVICES, LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SALIX PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Abbott2. AbbVie Inc.3. ALLERGAN4. AstraZeneca5. Bayer AG6. GlaxoSmithKline plc.7. Janssen Global Services, LLC8. Pfizer Inc.9. Salix Pharmaceuticals10. Takeda Pharmaceutical Company Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For